SCNX
Quality Rating
Scienture Holdings, Inc. (SCNX), a healthcare IT company providing an online platform for pharmaceutical distribution, demonstrates a permissible core business under Shariah principles but faces challenges in financial screening due to elevated debt levels. The company's operations focus on facilitating trade in essential medicines to hospitals and pharmacies, aligning with Islamic emphasis on beneficial commerce. However, quantitative ratios indicate non-compliance with major standards, primarily driven by a debt-to-market-cap ratio exceeding thresholds. No significant non-permissible income sources were identified, and ESG factors present low risk with resolved minor controversies. Overall, while the business model is strong, financial leverage requires monitoring for future compliance.
Purification Required
Minimal purification needed for dividend income
Index Inclusion
Not included in S&P Dow Jones Shariah Indices, MSCI Islamic Indices, FTSE Shariah Indices, or Dow Jones Islamic Market (DJIM)
Key Compliance Considerations
- Debt Ratio: 37.49% (exceeds AAOIFI 30%, MSCI 33.33%, S&P 33% thresholds)
Debt Ratio
37.5%
Liquidity Ratio
20.2%
Interest Income Ratio
0.0%
Purification
0.00%